Abstract

Objective: To explore the cerebral hemodynamic changes after revascularization in patients with hemorrhagic moyamoya disease (MMD).Materials and Methods: We retrospectively included 57 hemorrhagic MMD patients in a high-volume stroke center from January 2016 to December 2018. All subjects were evaluated with whole-brain CT perfusion (CTP) before and after surgical revascularization. Absolute and relative CTP values in the regions of cortical middle cerebral artery territory (CMT) and deep brain area (DBA) of hemorrhagic hemispheres were measured. Differences between pre- and post-operative CTP values were assessed comprehensively. The patients were categorized into subgroups based on revascularization subtypes and postoperative CTP intervals.Results: The relative cerebral blood volume (rCBV) in DBA and CMT significantly reduced in postoperative CTP (P < 0.05). The median and interquartile range of the proportion of rCBV decrease (rCBVc%) were 7.2% (2.3–13.2%). The rCBV reduction retained statistical significant in patients who received subtypes of revascularization, and in patients with variable intervals of follow-up (P < 0.05). There was no significant difference of rCBVc% between patients who received different revascularization and among patients with different postoperative CTP intervals (P > 0.05). The relative mean transit time (rMTT) and relative time to peak (rTTP) also showed downward trends, but without retainable statistical significance in stratified analysis. There was no significant change in relative cerebral blood flow (rCBF) (P > 0.05).Conclusion: In patients with hemorrhagic MMD, the CBV appeared to decrease and be relatively stable in the chronic phase after revascularization, with varying degrees of MTT and TTP shortening. However, there was no significant change in CBF.

Highlights

  • Moyamoya disease (MMD) is a chronic cerebrovascular disease, characterized by bilateral stenosis or occlusion at the terminal portion of the internal carotid artery and formation of abnormal vascular network at the base of the brain with unknown etiology, and it is called moyamoya syndrome (MMS) if it is associated with an underlying disease [1,2,3]

  • It is believed that intracranial hemorrhage secondary to MMD occurs mainly owing to the rupture of abnormal moyamoya vessels, dilated collateral vessels, and complicated aneurysms [13,14,15]

  • We attempted to quantitatively analyze the cerebral hemodynamic changes in hemorrhagic MMD after surgical revascularization based on computed tomography (CT) perfusion (CTP)

Read more

Summary

Introduction

Moyamoya disease (MMD) is a chronic cerebrovascular disease, characterized by bilateral stenosis or occlusion at the terminal portion of the internal carotid artery and formation of abnormal vascular network at the base of the brain with unknown etiology, and it is called moyamoya syndrome (MMS) if it is associated with an underlying disease [1,2,3]. It is believed that intracranial hemorrhage secondary to MMD occurs mainly owing to the rupture of abnormal moyamoya vessels, dilated collateral vessels, and complicated aneurysms [13,14,15]. Some studies have shown that revascularization surgery could promote the regression of dilated collaterals and complicated aneurysms, and decrease the risk of rebleeding in patients with hemorrhagic MMD [16,17,18]. With the regression of these collaterals, how the perfusion of brain tissue changes and whether brain tissue will face a higher risk of ischemia are still unclear. We attempted to quantitatively analyze the cerebral hemodynamic changes in hemorrhagic MMD after surgical revascularization based on CT perfusion (CTP)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.